CLINICAL_TRIALS
trial_result
· 2018-09-14
Clinical Trial Update: Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease [Phase 3]
Summary
Phase 3 trial investigating intravenous vedolizumab for mucosal healing in Crohn's disease has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Crohn's Disease | Phase 3 | Status: COMPLETED | Results posted: 2018-09-14